These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2866493)

  • 21. Bromazepam and diazepam in generalized anxiety: a placebo-controlled study with measurement of drug plasma concentrations.
    Fontaine R; Annable L; Chouinard G; Ogilvie RI
    J Clin Psychopharmacol; 1983 Apr; 3(2):80-7. PubMed ID: 6132936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anxiety in primary care: is short-term drug treatment appropriate?
    Tyrer P; Owen R
    J Psychiatr Res; 1984; 18(1):73-8. PubMed ID: 6371225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-sedation potential of buspirone compared with alprazolam and lorazepam in the treatment of anxious patients: a double-blind study.
    Cohn JB; Wilcox CS
    J Clin Psychiatry; 1986 Aug; 47(8):409-12. PubMed ID: 2874128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review of the side-effect profile of buspirone.
    Newton RE; Marunycz JD; Alderdice MT; Napoliello MJ
    Am J Med; 1986 Mar; 80(3B):17-21. PubMed ID: 2870641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of a putative anxiolytic agent: ipsapirone.
    Borison RL; Albrecht JW; Diamond BI
    Psychopharmacol Bull; 1990; 26(2):207-10. PubMed ID: 1978371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
    Pollack MH; Worthington JJ; Manfro GG; Otto MW; Zucker BG
    J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alprazolam versus buspirone in the treatment of outpatients with generalized anxiety disorder.
    Enkelmann R
    Psychopharmacology (Berl); 1991; 105(3):428-32. PubMed ID: 1798836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic effects and effects on actual driving performance of chronically administered buspirone and diazepam in anxious outpatients.
    van Laar MW; Volkerts ER; van Willigenburg AP
    J Clin Psychopharmacol; 1992 Apr; 12(2):86-95. PubMed ID: 1573045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double-blind comparison of buspirone and clorazepate in anxious outpatients.
    Cohn JB; Bowden CL; Fisher JG; Rodos JJ
    Am J Med; 1986 Mar; 80(3B):10-6. PubMed ID: 2870640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative assessment of efficacy and withdrawal symptoms after 6 and 12 weeks' treatment with diazepam or buspirone.
    Murphy SM; Owen R; Tyrer P
    Br J Psychiatry; 1989 Apr; 154():529-34. PubMed ID: 2686797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anxiolytic efficacy of alprazolam compared to diazepam and placebo.
    Maletzky BM
    J Int Med Res; 1980; 8(2):139-43. PubMed ID: 6102940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double-blind study of metaclazepam versus diazepam treatment of outpatients with anxiety syndrome.
    Laakmann G; Blaschke D; Hippius H; Schewe S
    Pharmacopsychiatry; 1989 May; 22(3):120-5. PubMed ID: 2568645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
    Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E
    J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Buspirone and lorazepam in the treatment of generalized anxiety disorder in outpatients.
    Laakmann G; Schüle C; Lorkowski G; Baghai T; Kuhn K; Ehrentraut S
    Psychopharmacology (Berl); 1998 Apr; 136(4):357-66. PubMed ID: 9600581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study.
    Dunner DL; Ishiki D; Avery DH; Wilson LG; Hyde TS
    J Clin Psychiatry; 1986 Sep; 47(9):458-60. PubMed ID: 2875064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of the efficacy of buspirone in patients affected by generalized anxiety disorder, shifting to buspirone from prior treatment with lorazepam: a placebo-controlled, double-blind study.
    Delle Chiaie R; Pancheri P; Casacchia M; Stratta P; Kotzalidis GD; Zibellini M
    J Clin Psychopharmacol; 1995 Feb; 15(1):12-9. PubMed ID: 7714222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Buspirone--a new antianxiety agent not chemically related to any presently marketed drugs [proceedings].
    Goldberg HL
    Psychopharmacol Bull; 1979 Apr; 15(2):90-2. PubMed ID: 34846
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy and safety of two dosing regimens of buspirone in the treatment of outpatients with persistent anxiety.
    Sramek JJ; Frackiewicz EJ; Cutler NR
    Clin Ther; 1997; 19(3):498-506. PubMed ID: 9220214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prior benzodiazepine use and buspirone response in the treatment of generalized anxiety disorder.
    DeMartinis N; Rynn M; Rickels K; Mandos L
    J Clin Psychiatry; 2000 Feb; 61(2):91-4. PubMed ID: 10732655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy and withdrawal of clobazam, lorazepam and buspirone in the treatment of anxiety disorders].
    Lemoine P; Rouillon F; Pouget D
    Encephale; 1996; 22(6):461-7. PubMed ID: 10901839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.